paper-with-me

Papers

HGTDR: Advancing Drug Repurposing with Heterogeneous Graph Transformers

2024-05-12 · Ali Gharizadeh, Karim Abbasi, Amin Ghareyazi, Mohammad R. K. Mofrad, Hamid R. Rabiee

Motivation: Drug repurposing is a viable solution for reducing the time and cost associated with drug development. However, thus far, the proposed drug repurposing approaches still need to meet expectations. Therefore, it is crucial to offer a systematic approach for drug repurposing to achieve cost savings and enhance human lives. In recent years, using biological network-based methods for drug repurposing has generated promising results. Nevertheless, these methods have limitations. Primarily, the scope of these methods is generally limited concerning the size and variety of data they can effectively handle. Another issue arises from the treatment of heterogeneous data, which needs to be addressed or converted into homogeneous data, leading to a loss of information. A significant drawback is that most of these approaches lack end-to-end functionality, necessitating manual implementation and expert knowledge in certain stages. Results: We propose a new solution, HGTDR (Heterogeneous Graph Transformer for Drug Repurposing), to address the challenges associated with drug repurposing. HGTDR is a three-step approach for knowledge graph-based drug re-purposing: 1) constructing a heterogeneous knowledge graph, 2) utilizing a heterogeneous graph transformer network, and 3) computing relationship scores using a fully connected network. By leveraging HGTDR, users gain the ability to manipulate input graphs, extract information from diverse entities, and obtain their desired output. In the evaluation step, we demonstrate that HGTDR performs comparably to previous methods. Furthermore, we review medical studies to validate our method's top ten drug repurposing suggestions, which have exhibited promising results. We also demon-strated HGTDR's capability to predict other types of relations through numerical and experimental validation, such as drug-protein and disease-protein inter-relations.

📄 PDF Abstract BibTeX arXiv:2405.08031

Code (0)

등록된 구현이 없습니다.

Methods 이 논문이 사용한 방법론

Linear Layer A Linear Layer is a projection $\mathbf{XW + b}$.
LapEigen 설명 없음
Multi-Head Attention 설명 없음
Dense Connections Dense Connections, or Fully Connected Connections, are a type of layer in a deep neural network that use a linear operation where every input is connected to every output…
Position-Wise Feed-Forward Layer 설명 없음
Dropout Dropout is a regularization technique for neural networks that drops a unit (along with connections) at training time with a specified probability $p$ (a common value is…
Label Smoothing Label Smoothing is a regularization technique that introduces noise for the labels. This accounts for the fact that datasets may have mistakes in them, so maximizing the…
Residual Connection 설명 없음

Similar Papers 제목 키워드 기반

Demystifying Drug Repurposing Domain Comprehension with Knowledge Graph Embedding

2021-08-30 · Edoardo Ramalli, Alberto Parravicini, Guido Walter Di Donato, Mirko Salaris 외

Drug repurposing is more relevant than ever due to drug development's rising costs and the need to respond to emerging diseases quickly. Knowledge graph embedding enables drug repurposing using heterogeneous data sources…

BIG-bench Machine LearningGraph EmbeddingKnowledge Graph Embedding

Conversational No-code, Multi-agentic Disease Module Identification and Drug Repurposing Prediction with ChatDRex

2025-11-26 · Simon Süwer, Kester Bagemihl, Sylvie Baier, Lucia Dicunta 외 arxiv

Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collabo…

A clustering and graph deep learning-based framework for COVID-19 drug repurposing

2023-06-24 · Chaarvi Bansal, Rohitash Chandra, Vinti Agarwal, P. R. Deepa

Drug repurposing (or repositioning) is the process of finding new therapeutic uses for drugs already approved by drug regulatory authorities (e.g., the Food and Drug Administration (FDA) and Therapeutic Goods Administrat…

Clustering

Drug Repurposing Using Deep Embedded Clustering and Graph Neural Networks

2025-09-15 · Luke Delzer, Robert Kroleski, Ali K. AlShami, Jugal Kalita arxiv

Drug repurposing has historically been an economically infeasible process for identifying novel uses for abandoned drugs. Modern machine learning has enabled the identification of complex biochemical intricacies in candi…

Graph Neural NetworkLink Prediction

Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing

2020-12-03 · Siddhant Doshi, Sundeep Prabhakar Chepuri

The 2019 novel coronavirus (SARS-CoV-2) pandemic has resulted in more than a million deaths, high morbidities, and economic distress worldwide. There is an urgent need to identify medications that would treat and prevent…

Drug DesignGraph Neural NetworkLink Prediction